Clinical Trials Logo

Jaundice and Sepsis in Neonates clinical trials

View clinical trials related to Jaundice and Sepsis in Neonates.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03133637 Completed - Clinical trials for Jaundice and Sepsis in Neonates

Ceftriaxone and Jaundice in Neonates

CEFT
Start date: March 2016
Phase:
Study type: Observational

Ceftriaxone is an antibiotic often used for the management of sepsis. Neonates commonly have jaundice during the first postnatal week. Ceftriaxone will be given as standard of care for sepsis and investigators will observe the effect on jaundice.